Epigenetic modulation in the treatment of atherosclerotic disease

Frontiers in Genetics

Volumn 5, Issue OCT, 2014, Pages

  Byrne, Mikaela M ^a   Murphy, Ross T ^a   Ryan, Anthony W ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Atherosclerosis; Cardiovascular disease; DNA methyltransferase inhibition; Epigenetic targeting agents; Histone deacetylase inhibition; MicroRNA

Indexed keywords

COLLAGEN TYPE 1; CURCUMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GAMMA INTERFERON; HEME OXYGENASE 1; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INTERFERON; LOW DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASE; METHYLTRANSFERASE; MICRORNA; MICRORNA 100; MICRORNA 127; MICRORNA 133A; MICRORNA 133B; MICRORNA 145; MICRORNA 21; MICRORNA 24; MICRORNA 92A; PROTOCATECHUALDEHYDE; SALVIA MILTIORRHIZA EXTRACT; SULFORAPHANE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNTRANSLATED RNA; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; BROCCOLI; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HUMAN; NONHUMAN; PROTEIN PROCESSING; REVIEW;

BRASSICA OLERACEA VAR. ITALICA;

EID: 84949116792     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00364     Document Type: Review

References (104)

1. Abifadel, M., Varret, M., Rabès, J.-P., Allard, D., Ouguerram, K., Devillers, M.,et al. (2003). Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34, 154-156. doi: 10.1038/ng1161
2. Alexy, T., James, A. M., and Searles, C. D. (2014). Shear sensitive microRNAs and atherosclerosis. Biorheology 51, 147-158. doi: 10.3233/BIR-140657
3. Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., and Schapira, M. (2012). Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug Discov. 11, 384-400. doi: 10.1038/nrd3674
4. Baccarelli, A., Rienstra, M., and Benjamin, E. J. (2010a). Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ. Cardiovasc. Genet. 3, 567-573. doi: 10.1161/CIRCGENETICS.110.958744
5. Baccarelli, A., Wright, R., Bollati, V., Litonjua, A., Zanobetti, A., Tarantini, L.,et al. (2010b). Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 21, 819-828. doi: 10.1097/EDE.0b013e3181f20457
6. Bai, Y., Cui, W., Xin, Y., Miao, X., Barati, M. T., Zhang, C.,et al. (2013). Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. J. Mol. Cell. Cardiol. 57, 82-95. doi: 10.1016/j.yjmcc.2013.01.008
7. Bentzon, J. F., Otsuka, F., Virmani, R., and Falk, E. (2014). Mechanisms of plaque formation and rupture. Circ. Res. 114, 1852-1866. doi: 10.1161/CIRCRESAHA.114.302721
8. Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21. doi: 10.1101/gad.947102
9. Bleijerveld, O. B., Zhang, Y.-N., Beldar, S., Hoefer, I. E., Sze, S. K., Pasterkamp, G.,et al. (2013). Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis. Proteomics Clin. Appl. 7, 490-503. doi: 10.1002/prca.201200119
10. Boettger, T., Beetz, N., Kostin, S., Schneider, J., Krüger, M., Hein, L.,et al. (2009). Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 119, 2634-2647. doi: 10.1172/JCI38864
11. Bruneau, B. G. (2010). Epigenetic regulation of the cardiovascular system: introduction to a review series. Circ. Res. 107, 324-326. doi: 10.1161/RES.0b013e3181f17dfe
12. Burdge, G. C., and Lillycrop, K. A. (2010). Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annu. Rev. Nutr. 30, 315-339. doi: 10.1146/annurev.nutr.012809.104751
13. Buysschaert, I., Schmidt, T., Roncal, C., Carmeliet, P., and Lambrechts, D. (2008). Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis. J. Cell. Mol. Med. 12, 2533-2551. doi: 10.1111/j.1582-4934.2008.00515.x
14. Bygren, L. O., Tinghög, P., Carstensen, J., Edvinsson, S., Kaati, G., Pembrey, M. E.,et al. (2014). Change in paternal grandmothers' early food supply influenced cardiovascular mortality of the female grandchildren. BMC Genet. 15:12. doi: 10.1186/1471-2156-15-12
15. Castro, R., Rivera, I., Blom, H. J., Jakobs, C., and Tavares de Almeida, I. (2006). Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J. Inherit. Metab. Dis. 29, 3-20. doi: 10.1007/s10545-006-0106-5
16. Chen, H.-H., Almontashiri, N. A. M., Antoine, D., and Stewart, A. F. R. (2014). Functional genomics of the 9p21.3 locus for atherosclerosis: clarity or confusion? Curr. Cardiol. Rep. 16, 502. doi: 10.1007/s11886-014-0502-7
17. Chen, N. C., Yang, F., Capecci, L. M., Gu, Z., Schafer, A. I., Durante, W.,et al. (2010). Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J. 24, 2804-2817. doi: 10.1096/fj.09-143651
18. Chen, X.-L., Dodd, G., and Kunsch, C. (2009). Sulforaphane inhibits TNF-alpha-induced activation of p38 MAP kinase and VCAM-1 and MCP-1 expression in endothelial cells. Inflamm. Res. 58, 513-521. doi: 10.1007/s00011-009-0017-7
19. Cipollone, F., Felicioni, L., Sarzani, R., Ucchino, S., Spigonardo, F., Mandolini, C.,et al. (2011). A unique microRNA signature associated with plaque instability in humans. Stroke 42, 2556-2563. doi: 10.1161/STROKEAHA.110.597575
20. Coban, D., Milenkovic, D., Chanet, A., Khallou-Laschet, J., Sabbe, L., Palagani, A.,et al. (2012). Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol. Nutr. Food Res. 56, 1270-1281. doi: 10.1002/mnfr.201100818
21. Cybulsky, M. I., and Gimbrone, M. A. Jr. (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791. doi: 10.1126/science.1990440
22. Daxinger, L., and Whitelaw, E. (2010). Transgenerational epigenetic inheritance: more questions than answers. Genome Res. 20, 1623-1628. doi: 10.1101/gr.106138.110
23. Deiuliis, J., Mihai, G., Zhang, J., Taslim, C., Varghese, J. J., Maiseyeu, A.,et al. (2014). Renin-sensitive microRNAs correlate with atherosclerosis plaque progression. J. Hum. Hypertens. 28, 251-258. doi: 10.1038/jhh.2013.97
24. De Nigris, F., Lerman, L. O., and Napoli, C. (2002). New insights in the transcriptional activity and coregulator molecules in the arterial wall. Int. J. Cardiol. 86, 153-168. doi: 10.1016/S0167-5273(02)00328-5
25. De Paoli, F., Staels, B., and Chinetti-Gbaguidi, G. (2014). Macrophage phenotypes and their modulation in atherosclerosis. Circ. J. 78, 1775-1781. doi: 10.1253/circj.CJ-14-0621
26. De Ruijter, A. J. M., van Gennip, A. H., Caron, H. N., Kemp, S., and van Kuilenburg, A. B. P. (2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749. doi: 10.1042/BJ20021321
27. Di Gregoli, K., Jenkins, N., Salter, R., White, S., Newby, A. C., and Johnson, J. L. (2014). MicroRNA-24 regulates macrophage behavior and retards atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 34, 1990-2000. doi: 10.1161/ATVBAHA.114.304088
28. Dominguez-Salas, P., Moore, S. E., Baker, M. S., Bergen, A. W., Cox, S. E., Dyer, R. A.,et al. (2014). Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat. Commun. 5, 3746. doi: 10.1038/ncomms4746
29. Dupont, C., Armant, D. R., and Brenner, C. A. (2009). Epigenetics: definition, mechanisms, and clinical perspective. Semin. Reprod. Med. 27, 351-357. doi: 10.1055/s-0029-1237423
30. Egger, G., Liang, G., Aparicio, A., and Jones, P. A. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463. doi: 10.1038/nature02625
31. Elbarbry, F., and Elrody, N. (2011). Potential health benefits of sulforaphane: a review of the experimental, clinical, and epidemiological evidences and underlying mechanisms. J. Med. Plants Res. 5, 473-484.
32. Eom, G. H., and Kook, H. (2014). Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases. Pharmacol. Ther. 143, 168-180. doi: 10.1016/j.pharmthera.2014.02.012
33. Evans, P. C. (2011). The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease. EPMA J. 2, 9-14. doi: 10.1007/s13167-011-0064-3
34. Fan, X., Wang, E., Wang, X., Cong, X., and Chen, X. (2014). MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs. Exp. Mol. Pathol. 96, 242-249. doi: 10.1016/j.yexmp.2014.02.009
35. Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C.,et al. (2010). Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684. doi: 10.1161/CIRCRESAHA.109.215566
36. Findeisen, H. M., Kahles, F. K., and Bruemmer, D. (2013). Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis. Curr. Atheroscler. Rep. 15, 319. doi: 10.1007/s11883-013-0319-7
37. Fitzgerald, K., Frank-Kamenetsky, M., Shulga-Morskaya, S., Liebow, A., Bettencourt, B. R., Sutherland, J. E.,et al. (2014). Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial. Lancet 383, 60-68. doi: 10.1016/S0140-6736(13)61914-5
38. Hansson, G. K., and Hermansson, A. (2011). The immune system in atherosclerosis. Nat. Immunol. 12, 204-212. doi: 10.1038/ni.2001
39. Hansson, G. K., and Libby, P. (2006). The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6, 508-519. doi: 10.1038/nri1882
40. Hao, L., Wang, X.-G., Cheng, J.-D., You, S.-Z., Ma, S.-H., Zhong, X.,et al. (2014). The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human atherosclerotic coronary artery. Cardiovasc. Pathol. 23, 217-223. doi: 10.1016/j.carpath.2014.03.009
41. Hoeksema, M. A., Gijbels, M. J., Van den Bossche, J., van der Velden, S., Sijm, A., Neele, A. E.,et al. (2014). Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol. Med. 6, 1124-1132. doi: 10.15252/emmm.201404170
42. Holdt, L. M., Hoffmann, S., Sass, K., Langenberger, D., Scholz, M., Krohn, K.,et al. (2013). Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet. 9:e1003588. doi: 10.1371/journal.pgen.1003588
43. Hu, Y.-W., Hu, Y.-R., Zhao, J.-Y., Li, S.-F., Ma, X., Wu, S.-G.,et al. (2014a). An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production. PLoS ONE 9:e94997. doi: 10.1371/journal.pone.0094997
44. Hu, Y.-W., Yang, J.-Y., Ma, X., Chen, Z.-P., Hu, Y.-R., Zhao, J.-Y.,et al. (2014b). A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis. J. Lipid Res. 55, 681-697. doi: 10.1194/jlr.M044669
45. Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X.,et al. (2012). Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Ed Engl. 51, 8529-8533. doi: 10.1002/anie.201203263
46. Jia, L., Zhu, L., Wang, J. Z., Wang, X. J., Chen, J. Z., Song, L.,et al. (2013). Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease. Atherosclerosis 228, 346-352. doi: 10.1016/j.atherosclerosis.2013.01.027
47. Jonasson, L., Holm, J., Skalli, O., Bondjers, G., and Hansson, G. K. (1986). Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131-138. doi: 10.1161/01.ATV.6.2.131
48. Juurlink, B. H. J. (2012). Dietary Nrf2 activators inhibit atherogenic processes. Atherosclerosis 225, 29-33. doi: 10.1016/j.atherosclerosis.2012.08.032
49. Kaati, G., Bygren, L. O., and Edvinsson, S. (2002). Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur. J. Hum. Genet. 10, 682-688. doi: 10.1038/sj.ejhg.5200859
50. Kaikkonen, M. U., Lam, M. T. Y., and Glass, C. K. (2011). Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc. Res. 90, 430-440. doi: 10.1093/cvr/cvr097
51. Kilpinen, H., and Dermitzakis, E. T. (2012). Genetic and epigenetic contribution to complex traits. Hum. Mol. Genet. 21, R24-R28. doi: 10.1093/hmg/dds383
52. Kim, J., Kim, J. Y., Song, K. S., Lee, Y. H., Seo, J. S., Jelinek, J.,et al. (2007). Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim. Biophys. Acta 1772, 72-80. doi: 10.1016/j.bbadis.2006.10.004
53. Kim, J.-Y., Park, H.-J., Um, S. H., Sohn, E.-H., Kim, B.-O., Moon, E.-Y.,et al (2012). Sulforaphane suppresses vascular adhesion molecule-1 expression in TNF-α-stimulated mouse vascular smooth muscle cells: involvement of the MAPK, NF-κB and AP-1 signaling pathways. Vascul. Pharmacol. 56, 131-141. doi: 10.1016/j.vph.2011.11.007
54. Kim, M., Long, T. I., Arakawa, K., Wang, R., Yu, M. C., and Laird, P. W. (2010). DNA methylation as a biomarker for cardiovascular disease risk. PLoS ONE 5:e9692. doi: 10.1371/journal.pone.0009692
55. Kong, X., Fang, M., Li, P., Fang, F., and Xu, Y. (2009). HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells. J. Mol. Cell. Cardiol. 46, 292-299. doi: 10.1016/j.yjmcc.2008.10.023
56. Lalande, M. (1996). Parental imprinting and human disease. Annu. Rev. Genet. 30, 173-195. doi: 10.1146/annurev.genet.30.1.173
57. Lenfant, C. (2013). Prospects of personalized medicine in cardiovascular diseases. Metabolism 62(Suppl. 1), S6-S10. doi: 10.1016/j.metabol.2012.08.018
58. Libby, P., Okamoto, Y., Rocha, V. Z., and Folco, E. (2010). Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 74, 213-220.
59. Liu, R., Leslie, K. L., and Martin, K. A. (2014a). Epigenetic regulation of smooth muscle cell plasticity. Biochim. Biophys. Acta doi: 10.1016/j.bbagrm.2014.06.004 [Epub ahead of print].
60. Liu, T., Huang, Y., Chen, J., Chi, H., Yu, Z., Wang, J.,et al. (2014b). Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1-AS expression. Mol. Med. Rep. 10, 1275-1281. doi: 10.3892/mmr.2014.2351
61. Loyer, X., Potteaux, S., Vion, A.-C., Guérin, C. L., Boulkroun, S., Rautou, P.-E.,et al. (2014). Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ. Res. 114, 434-443. doi: 10.1161/CIRCRESAHA.114.302213
62. Maloyan, A., Muralimanoharan, S., Huffman, S., Cox, L. A., Nathanielsz, P. W., Myatt, L.,et al. (2013). Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity. Physiol. Genomics 45, 889-900. doi: 10.1152/physiolgenomics.00050.2013
63. McNeil, C. J., Beattie, J. H., Gordon, M.-J., Pirie, L. P., and Duthie, S. J. (2011). Differential effects of nutritional folic acid deficiency and moderate hyperhomocysteinemia on aortic plaque formation and genome-wide DNA methylation in vascular tissue from ApoE-/- mice. Clin. Epigenetics 2, 361-368. doi: 10.1007/s13148-011-0022-x
64. Menghini, R., Stöhr, R., and Federici, M. (2014). MicroRNAs in vascular aging and atherosclerosis. Ageing Res. Rev. 17C, 68-78. doi: 10.1016/j.arr.2014.03.005
65. Mercer, T. R., Dinger, M. E., and Mattick, J. S. (2009). Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10, 155-159. doi: 10.1038/nrg2521
66. Miao, X., Bai, Y., Sun, W., Cui, W., Xin, Y., Wang, Y.,et al. (2012). Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants. Nutr. Metab. (Lond.) 9, 84. doi: 10.1186/1743-7075-9-84
67. Milenkovic, D., Vanden Berghe, W., Boby, C., Leroux, C., Declerck, K., Szarc vel Szic, K.,et al. (2014). Dietary flavanols modulate the transcription of genes associated with cardiovascular pathology without changes in their DNA methylation state. PLoS ONE 9:e95527. doi: 10.1371/journal.pone.0095527
68. Moon, C. Y., Ku, C. R., Cho, Y. H., and Lee, E. J. (2012). Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis. Biochem. Biophys. Res. Commun. 423, 116-121. doi: 10.1016/j.bbrc.2012.05.092
69. Moore, K. J., and Tabas, I. (2011). Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355. doi: 10.1016/j.cell.2011.04.005
70. Motterle, A., Pu, X., Wood, H., Xiao, Q., Gor, S., Ng, F. L.,et al. (2012). Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Hum. Mol. Genet. 21, 4021-4029. doi: 10.1093/hmg/dds224
71. Myzak, M. C., Tong, P., Dashwood, W.-M., Dashwood, R. H., and Ho, E. (2007). Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp. Biol. Med. (Maywood) 232, 227-234.
72. Ordovas, J. M., and Smith, C. E. (2010). Epigenetics and cardiovascular disease. Nat. Rev. Cardiol. 7, 510-519. doi: 10.1038/nrcardio.2010.104
73. Painter, R. C., Osmond, C., Gluckman, P., Hanson, M., Phillips, D. I. W., and Roseboom, T. J. (2008). Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG 115, 1243-1249. doi: 10.1111/j.1471-0528.2008.01822.x
74. Poller, W., Tank, J., Skurk, C., and Gast, M. (2013). Cardiovascular RNA interference therapy the broadening tool and target spectrum. Circ. Res. 113, 588-602. doi: 10.1161/CIRCRESAHA.113.301056
75. Pons, D., de Vries, F. R., van den Elsen, P. J., Heijmans, B. T., Quax, P. H. A., and Jukema, J. W. (2009). Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur. Heart J. 30, 266-277. doi: 10.1093/eurheartj/ehn603
76. Ponting, C. P., Oliver, P. L., and Reik, W. (2009). Evolution and functions of long noncoding RNAs. Cell 136, 629-641. doi: 10.1016/j.cell.2009.02.006
77. Pucci, S., Fisco, T., Zonetti, M. J., Bonanno, E., Mazzarelli, P., and Mauriello, A. (2014). PTX3: a modulator of human coronary plaque vulnerability acting by macrophages type 2. Int. J. Cardiol. doi: 10.1016/j.ijcard.2014.07.109 [Epub ahead of print].
78. Raitoharju, E., Lyytikäinen, L.-P., Levula, M., Oksala, N., Mennander, A., Tarkka, M.,et al. (2011). miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219, 211-217. doi: 10.1016/j.atherosclerosis.2011.07.020
79. Raitoharju, E., Oksala, N., and Lehtimäki, T. (2013). MicroRNAs in the atherosclerotic plaque. Clin. Chem. 59, 1708-1721. doi: 10.1373/clinchem.2013.204917
80. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809. doi: 10.1038/362801a0
81. Rotllan, N., Ramírez, C. M., Aryal, B., Esau, C. C., and Fernández-Hernando, C. (2013). Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice-brief report. Arterioscler. Thromb. Vasc. Biol. 33, 1973-1977. doi: 10.1161/ATVBAHA.113.301732
82. Sharma, P., Kumar, J., Garg, G., Kumar, A., Patowary, A., Karthikeyan, G.,et al. (2008). Detection of Altered Global DNA Methylation in Coronary Artery Disease Patients. DNA Cell Biol. 27, 357-365. doi: 10.1089/dna.2007.0694
83. Shirodkar, A. V., and Marsden, P. A. (2011). Epigenetics in cardiovascular disease. Curr. Opin. Cardiol. 26, 209-215. doi: 10.1097/HCO.0b013e328345986e
84. Skinner, M. K., Mohan, M., Haque, M. M., Zhang, B., and Savenkova, M. I. (2012). Epigenetic transgenerational inheritance of somatic transcriptomes and epigenetic control regions. Genome Biol. 13:R91. doi: 10.1186/gb-2012-13-10-r91
85. Soriano-Tárraga, C., Jiménez-Conde, J., Giralt-Steinhauer, E., Mola, M., Ois, A., Rodríguez-Campello, A.,et al. (2014). Global DNA methylation of ischemic stroke subtypes. PLoS ONE 9:e96543. doi: 10.1371/journal.pone.0096543
86. Stein, S., and Matter, C. M. (2011). Protective roles of SIRT1 in atherosclerosis. Cell Cycle 10, 640-647. doi: 10.4161/cc.10.4.14863
87. Stellos, K., and Dimmeler, S. (2014). Vascular MicroRNAs: From Disease Mechanisms to Therapeutic Targets. Circ. Res. 114, 3-4. doi: 10.1161/CIRCRESAHA.113.302762
88. Sutaria, D., Grandhi, B., Thakkar, A., Wang, J., and Prabhu, S. (2012). Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Int. J. Oncol. 41, 2260-2268. doi: 10.3892/ijo.2012.1636
89. van Kampen, E., Jaminon, A., van Berkel, T. J. C., and Van Eck, M. (2014). Diet-induced (epigenetic) changes in bone marrow augment atherosclerosis. J. Leukoc. Biol. doi: 10.1189/jlb.1A0114-017R [Epub ahead of print].
90. Vausort, M., Wagner, D. R. R., and Devaux, Y. (2014). Long non-coding RNAs in patients with acute myocardial infarction. Circ. Res. 115, 668-677. doi: 10.1161/CIRCRESAHA.115.303836
91. Weber, C., and Noels, H. (2011). Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 1410-1422. doi: 10.1038/nm.2538
92. Webster, A. L. H., Yan, M. S.-C., and Marsden, P. A. (2013). Epigenetics and cardiovascular disease. Can. J. Cardiol. 29, 46-57. doi: 10.1016/j.cjca.2012.10.023
93. Wei, G., Guan, Y., Yin, Y., Duan, J., Zhou, D., Zhu, Y.,et al. (2013). Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro. Inflammation 36, 592-602. doi: 10.1007/s10753-012-9581-z
94. Weng, X., Cheng, X., Wu, X., Xu, H., Fang, M., and Xu, Y. (2014). Sin3B mediates collagen type I gene repression by interferon gamma in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 447, 263-270. doi: 10.1016/j.bbrc.2014.03.140
95. Wierda, R. J., Geutskens, S. B., Jukema, J. W., Quax, P. H. A., and van den Elsen, P. J. (2010). Epigenetics in atherosclerosis and inflammation. J. Cell. Mol. Med. 14, 1225-1240. doi: 10.1111/j.1582-4934.2010.01022.x
96. Wilusz, J. E., Sunwoo, H., and Spector, D. L. (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 23, 1494-1504. doi: 10.1101/gad.1800909
97. Yamada, Y., Nishida, T., Horibe, H., Oguri, M., Kato, K., and Sawabe, M. (2014). Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation. Int. J. Mol. Med. 33, 1355-1363. doi: 10.3892/ijmm.2014.1692
98. Yan, M. S.-C., Matouk, C. C., and Marsden, P. A. (2010). Epigenetics of the vascular endothelium. J. Appl. Physiol. 1985 109, 916-926. doi: 10.1152/japplphysiol.00131.2010
99. Yoo, S.-H., Lim, Y., Kim, S.-J., Yoo, K.-D., Yoo, H.-S., Hong, J.-T.,et al. (2013). Sulforaphane inhibits PDGF-induced proliferation of rat aortic vascular smooth muscle cell by up-regulation of p53 leading to G1/S cell cycle arrest. Vascul. Pharmacol. 59, 44-51. doi: 10.1016/j.vph.2013.06.003
100. Zaina, S., Heyn, H., Carmona, F. J., Varol, N., Sayols, S., Condom, E.,et al. (2014). A DNA Methylation Map of Human Atherosclerosis. Circ. Cardiovasc. Genet. doi: 10.1161/CIRCGENETICS.113.000441 [Epub ahead of print]
101. Zakkar, M., Van der Heiden, K., Luong, L. A., Chaudhury, H., Cuhlmann, S., Hamdulay, S. S.,et al. (2009). Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler. Thromb. Vasc. Biol. 29, 1851-1857. doi: 10.1161/ATVBAHA.109.193375
102. Zhang, C., Su, Z.-Y., Khor, T. O., Shu, L., and Kong, A.-N. T. (2013). Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochem. Pharmacol. 85, 1398-1404. doi: 10.1016/j.bcp.2013.02.010
103. Zhao, Z., Tuakli-Wosornu, Y., Lagace, T. A., Kinch, L., Grishin, N. V., Horton, J. D.,et al. (2006). Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am. J. Hum. Genet. 79, 514-523. doi: 10.1086/507488
104. Zhou, Z., Liu, Y., Miao, A.-D., and Wang, S.-Q. (2005). Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur. J. Pharmacol. 513, 1-8. doi: 10.1016/j.ejphar.2005.01.059